Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28) U. GiriN. H. A. TerryM. D. Story Original Article 11 March 2005 Pages: 511 - 521
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors Grace K. DyAjit SuriAlex A. Adjei Original Article 08 March 2005 Pages: 522 - 530
Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells Chi-Chih ChengShu-Mei YangShih-Lan Hsu Original Article 01 March 2005 Pages: 531 - 540
5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens Omar N. Al SafarjalaniXiao-Jian ZhouMahmoud H. el Kouni Original Article 24 February 2005 Pages: 541 - 551
Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequences Maki AndoHideo SakaYoshinori Hasegawa Original Article 15 March 2005 Pages: 552 - 558
A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer Henry Q. XiongWilliam PlunkettJames L. Abbruzzese Original Article 22 February 2005 Pages: 559 - 564
Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies Debora G. RodriguesDurvanei A. MariaRaul C. Maranhão Original Article 22 February 2005 Pages: 565 - 576
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175 R. L. HaywardQ. C. SchornagelD. I. Jodrell Original Article 22 February 2005 Pages: 577 - 583
Gefitinib (Iressa, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells Osamu KishidaYoshiji MiyazakiYasuhisa Shinomura Original Article 19 February 2005 Pages: 584 - 594
In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines Risa TanakaHiroshi AriyamaShuji Nakano Original Article 25 February 2005 Pages: 595 - 601
Additive apoptotic effect of STI571 with the cytoprotective agent amifostine in K-562 cell line Luciano VellónMarcela González-CidIrene Larripa Original Article 08 February 2005 Pages: 602 - 608
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients Peter NygrenKenneth HandeSimon van Belle Clinical Trial Report 19 February 2005 Pages: 609 - 616
